Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Clascoterone vs Sunscreen (SPF): Sunscreen (SPF) has the stronger overall evidence (9 vs 7/10); the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Sunscreen (SPF) wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Clascoterone and Sunscreen (SPF) have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Morning and evening
Clascoterone 1% cream
Topical OTC. Apply a broad-spectrum SPF 30+ sunscreen daily to sun-exposed skin as the last step of a morning routine, using an adequate amount (about 2 mg/cm² — roughly a nickel-sized dollop for the face, a shot-glass for the body) and reapply every ~2 hours of sun exposure and after swimming/sweating. Mineral (zinc oxide / titanium dioxide) filters are preferred if you're concerned about systemic absorption. There is no oral or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
Morning
Broad-spectrum SPF 30+, applied daily; mineral (zinc oxide/titanium dioxide) if concerned about absorption
immediate
12 weeks
12 weeks
1-4 weeks
Throughout
Ongoing (years)
Ongoing
Throughout
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · RCT · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · RCT · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta-Analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Sunscreen and prevention of skin aging: a randomized trial.
Ann Intern Med (2013) · RCT · n=903
Randomized community trial (n=903): the daily sunscreen group showed no detectable increase in photoaging (skin microtopography) after 4.5 years
Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo.
J Investig Dermatol Symp Proc (1998) · Review
Mechanistic model: UV activates MAP-kinase pathways and AP-1, which upregulate matrix metalloproteinases (MMPs)
Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of Photoaging.
Dermatol Surg (2016) · Open-Label · n=32
Single-arm prospective study (n=32): broad-spectrum SPF 30 applied daily to the face for 52 weeks
Sunscreen (SPF) has a higher evidence score (9/10 vs 7/10) and wins in 3 of 3 categories.
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.